Therapeutic strategies to increase high-density lipoprotein (HDL) to treat or prevent vascular disease include the use of cholesteryl-ester transfer protein (CETP) inhibitors. Here, we show, to the best of our knowledge for the first time, that addition of CETP to HDL enhances the ability of HDL to
β¦ LIBER β¦
Treating high-density lipoprotein cholesterol: A return to inhibition of cholesteryl ester transfer protein?
β Scribed by Patrick Duriez
- Book ID
- 107534111
- Publisher
- Current Science Inc.
- Year
- 2008
- Tongue
- English
- Weight
- 98 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1523-3804
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Cholesteryl-ester transfer protein enhan
β
David Hine; Bharti Mackness; Mike Mackness
π
Article
π
2011
π
John Wiley and Sons
π
English
β 93 KB
Inhibition of cholesteryl ester transfer
β
Daniel J. Rader
π
Article
π
2004
π
Current Science Inc.
π
English
β 457 KB
Genetic variations in the cholesteryl es
β
Lung-An Hsu; Yu-Lin Ko; Kuang-Hung Hsu; Yu-Hsien Ko; Ying-Shiung Lee
π
Article
π
2001
π
Springer
π
English
β 45 KB
Association of cholesteryl ester transfe
β
Sevda Tanrikulu; Evin Ademoglu; Figen Gurdol; Umit Mutlu-Turkoglu; Ahmet Kaya Bi
π
Article
π
2009
π
John Wiley and Sons
π
English
β 112 KB
π 2 views
Variations in high-density lipoprotein c
β
M Mukherjee; KR Shetty
π
Article
π
2004
π
John Wiley and Sons
π
English
β 111 KB
Relationship of high-density lipoprotein
β
B. FΓΆger; G. Luef; A. Ritsch; C. Schmidauer; A. Doblinger; M. Lechleitner; F. Ai
π
Article
π
1995
π
Springer
π
English
β 410 KB
High plasma concentrations of high-density lipoprotein (HDL) cholesterol are a powerful indicator of low vascular risk. By decreasing HDL cholesterol, cholesteryl ester transfer protein (CETP) could perhaps constitute an atherogenic protein. We measured HDL cholesterol and HDL subfractions and quant